Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Overduin

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biochemical Society Transactions|November 21, 2002
Structure of complement receptor (CR) 2 and CR2-C3d complexesJ Hannan, K Young, G Szakonyi, et al.
Journal of Molecular Biology|December 4, 2003
Solution structure of the C-terminal antiparallel coiled-coil domain from Escherichia coli osmosensor ProPDavid L Zoetewey, Brian P Tripet, Tatiana G Kutateladze, et al.
The Chinese Journal of Physiology|February 16, 2016
A Heart too Drunk to Drive; AV Block following Acute Alcohol IntoxicationArthur H van Stigt, Ruben J Overduin, Liza C Staats, et al.
Orphanet Journal of Rare Diseases|January 9, 2025
A machine learning model accurately identifies glycogen storage disease Ia patients based on plasma acylcarnitine profilesJoost Groen, Bas M de Haan, Ruben J Overduin, et al.
JIMD Reports|July 8, 2024
Screening and surveillance of hepatocellular carcinoma by serum des-gamma-carboxy prothrombin in patients with glycogen storage disease type IaA B Schreuder, R J Overduin, N C Peltenburg, et al.
Molecular Genetics and Metabolism|September 7, 2024
Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational studyRuben J Overduin, Annieke Venema, Charlotte M A Lubout, et al.
Molecular Genetics and Metabolism|October 16, 2025
Urinary tetraglucoside excretion as a biomarker in liver glycogen storage diseasesRuben J Overduin, Candelas Gross-Valle, Joost Groen, et al.
Journal of Inherited Metabolic Disease|May 27, 2024
Repurposing SGLT2 inhibitors: Treatment of renal proximal tubulopathy in Fanconi-Bickel syndrome with empagliflozinRuben J Overduin, Sarah C Grünert, Martine T P Besouw, et al.
Journal of Inherited Metabolic Disease|January 8, 2024
Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value-based healthcare approach and systematic benefit-risk assessmentTerry G J Derks, Annieke Venema, Clara Köller, et al.
Communications Biology|November 9, 2024
Precision-cut liver slices as an ex vivo model to assess impaired hepatic glucose productionLigia Akemi Kiyuna, Kishore Alagere Krishnamurthy, Esther B Homan, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biochemical Society Transactions|November 21, 2002
Structure of complement receptor (CR) 2 and CR2-C3d complexesJ Hannan, K Young, G Szakonyi, et al.
Journal of Molecular Biology|December 4, 2003
Solution structure of the C-terminal antiparallel coiled-coil domain from Escherichia coli osmosensor ProPDavid L Zoetewey, Brian P Tripet, Tatiana G Kutateladze, et al.
The Chinese Journal of Physiology|February 16, 2016
A Heart too Drunk to Drive; AV Block following Acute Alcohol IntoxicationArthur H van Stigt, Ruben J Overduin, Liza C Staats, et al.
Orphanet Journal of Rare Diseases|January 9, 2025
A machine learning model accurately identifies glycogen storage disease Ia patients based on plasma acylcarnitine profilesJoost Groen, Bas M de Haan, Ruben J Overduin, et al.
JIMD Reports|July 8, 2024
Screening and surveillance of hepatocellular carcinoma by serum des-gamma-carboxy prothrombin in patients with glycogen storage disease type IaA B Schreuder, R J Overduin, N C Peltenburg, et al.
Molecular Genetics and Metabolism|September 7, 2024
Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational studyRuben J Overduin, Annieke Venema, Charlotte M A Lubout, et al.
Molecular Genetics and Metabolism|October 16, 2025
Urinary tetraglucoside excretion as a biomarker in liver glycogen storage diseasesRuben J Overduin, Candelas Gross-Valle, Joost Groen, et al.
Journal of Inherited Metabolic Disease|May 27, 2024
Repurposing SGLT2 inhibitors: Treatment of renal proximal tubulopathy in Fanconi-Bickel syndrome with empagliflozinRuben J Overduin, Sarah C Grünert, Martine T P Besouw, et al.
Journal of Inherited Metabolic Disease|January 8, 2024
Repurposing empagliflozin in individuals with glycogen storage disease Ib: A value-based healthcare approach and systematic benefit-risk assessmentTerry G J Derks, Annieke Venema, Clara Köller, et al.
Communications Biology|November 9, 2024
Precision-cut liver slices as an ex vivo model to assess impaired hepatic glucose productionLigia Akemi Kiyuna, Kishore Alagere Krishnamurthy, Esther B Homan, et al.
Pageof 3